Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-CD38 antibody and lenalidomide or bortezomib for the treatment of multipe myeloma and NHL

Anti-CD38 antibody and lenalidomide or bortezomib for the treatment of multipe myeloma and NHL

US Patent 8877899 · Granted Nov 4, 2014

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pharmaceutical combinations for treating tumor comprising anti-CD19 antibody and2025
Pharmaceutical combinations for treating tumor comprising anti-CD19 antibody and2025
Combination of anti CD19 antibody with a BCL-2 inhibitor and uses thereof2025
Combination of anti CD19 antibody with a BCL-2 inhibitor and uses thereof2025
Combinations and uses thereof2025
Combinations and uses thereof2025
Combinations and uses thereof2025
Treatment for multiple myeloma (MM)2023
Combinations and uses thereof2022
Combinations and uses thereof2022
Combinations and uses thereof2022
Combination of an anti-CD19 antibody and a Bruton's tyrosine kinase inhibitor an2020